Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
5.2
2.9
Journals
JCM
Special Issues
Clinical Diagnosis and Management of Neonatal Diseases
jcm-logo
Submit to Special Issue Submit Abstract to Special Issue Review for JCM Propose a Special Issue

Journal Menu

► Journal Menu

Journal Browser

► Journal Browser
share announcement

Clinical Diagnosis and Management of Neonatal Diseases

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Clinical Pediatrics".

Deadline for manuscript submissions: 20 December 2025 | Viewed by 4714

Special Issue Editors

Dr. Ayala Gover

E-Mail
Guest Editor
1. Neonatal Intensive Care Unit, Bnai-Zion Medical Center, Haifa 31048, Israel
2. The Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa 32000, Israel
Interests: neonatology; neonatal intensive care; neonatal hemodynamics; point of care ultrasound
Prof. Dr. Arieh Riskin

E-Mail
Guest Editor
1. Neonatal Intensive Care Unit, Bnai-Zion Medical Center, Haifa 31048, Israel
2. The Ruth & Bruce Rappaport Faculty of Medicine, Technion, Haifa 32000, Israel
Interests: neonatology; neonatal intensive care; low birth weight; neonatal nutrition

Special Issue Information

Dear Colleagues,

As the field of neonatology continues to evolve, we invite researchers to submit their original manuscripts to our Special Issue dedicated to the diagnosis and management of neonatal diseases. We welcome high-quality studies across a range of topics, including but not limited to neonatal care, preterm birth, neonatal respiratory and cardiovascular management, neurodevelopmental outcomes, and point-of-care ultrasound for neonatal conditions. Our goal is to highlight research that can inform clinical practice and improve outcomes for the most vulnerable patients. In this Special Issue, we encourage clinical research that provides new insights into the diagnosis, treatment, and care of neonates, with an emphasis on improving long-term health and development. Submissions will undergo a rigorous peer-review process. We warmly welcome researchers to contribute their work to this issue and look forward to receiving your innovative and impactful submissions.

Dr. Ayala Gover
Prof. Dr. Arieh Riskin
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • newborn
  • preterm
  • neonatal intensive care
  • low birth weight
  • point-of-care ultrasound
  • neonatal monitoring

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (6 papers)

Download All Papers
Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Research

Jump to: Review

9 pages, 195 KiB  
Article
Persistent Pulmonary Hypertension of the Newborn in Very Low Birth Weight Infants: Risk Factors and Clinical Outcomes from a Matched Case–Control Study
by Anucha Thatrimontrichai, Pattima Pakhathirathien, Manapat Praditaukrit, Gunlawadee Maneenil, Supaporn Dissaneevate, Ploypailin Jantarawongpisal and Jenjira Saechan
J. Clin. Med. 2025, 14(13), 4759; https://doi.org/10.3390/jcm14134759 - 4 Jul 2025
Viewed by 584
Abstract
Background/Objectives: To identify the risk factors and clinical outcomes of persistent pulmonary hypertension of the newborn (PPHN) in very low birth weight (VLBW) infants in a resource-limited setting. Methods: We conducted a 1:4 matched case–control study in a Thai neonatal unit [...] Read more.
Background/Objectives: To identify the risk factors and clinical outcomes of persistent pulmonary hypertension of the newborn (PPHN) in very low birth weight (VLBW) infants in a resource-limited setting. Methods: We conducted a 1:4 matched case–control study in a Thai neonatal unit between 2014 and 2023. Neonates born at a gestational age (GA) < 32 weeks and with a birth weight (BW) < 1500 g were included. Neonates who died in the delivery room or had major congenital anomalies were excluded. Matching was based on GA, BW, year of birth, and endotracheal intubation at birth. Conditional logistic regression analysis was performed. Results: Over the 10-year study period, the incidence of PPHN among VLBW neonates was 4.6% (31/667). After matching, there were 31 cases and 124 controls. In univariable analysis, PPHN was significantly associated with lower 1 min and 5 min Apgar scores; however, no significant association remained in multivariable analysis. PPHN was significantly associated with composite adverse outcomes—including mortality and major morbidities (adjusted odds ratio [aOR] = 7.51, 95% confidence interval [CI]: 2.41–23.40), mortality alone (aOR = 2.88, 95% CI: 1.06–7.63), major morbidities (aOR = 2.99; 95% CI: 1.29–6.95), and severe neurological injury (aOR = 4.44, 95% CI: 1.56–12.59). Daily hospital costs were also higher in PPHN cases, with an average increase of 97.1 USD. Conclusions: In VLBW infants, PPHN was associated with a lower Apgar score and surfactant administration. PPHN was significantly linked to adverse outcomes, particularly mortality, major morbidities, and severe neurological injury. Full article
(This article belongs to the Special Issue Clinical Diagnosis and Management of Neonatal Diseases)
11 pages, 440 KiB  
Article
Mortality Risk Factors and Survival Outcomes in Infants with Persistent Pulmonary Hypertension of the Newborn
by Kokaew Chuaikaew, Gunlawadee Maneenil, Anucha Thatrimontrichai, Supaporn Dissaneevate and Manapat Praditaukrit
J. Clin. Med. 2025, 14(13), 4502; https://doi.org/10.3390/jcm14134502 - 25 Jun 2025
Viewed by 517
Abstract
Background/Objectives: Persistent pulmonary hypertension of the newborn (PPHN) is characterized by increased pulmonary vascular resistance, resulting in severe hypoxemia. This study determined the factors associated with increased risk of mortality and survival rate in infants with PPHN. Methods: This retrospective study [...] Read more.
Background/Objectives: Persistent pulmonary hypertension of the newborn (PPHN) is characterized by increased pulmonary vascular resistance, resulting in severe hypoxemia. This study determined the factors associated with increased risk of mortality and survival rate in infants with PPHN. Methods: This retrospective study was conducted between 2010 and 2023. The risk factors for mortality were assessed by Cox’s proportional hazard models, and the Kaplan–Meier survival curve was used to analyze the survival rates. Results: This study included 233 neonates with PPHN. Gestational age (GA) less than 28 weeks (adjusted hazard ratio [AHR] = 5.46, 95% confidence interval [CI]: 2.25–13.24, p < 0.001), Small for gestational age (SGA) (AHR = 2.93, 95% confidence interval [CI]: 1.24–6.92, p = 0.026), acute kidney injury (AKI) (AHR = 2.48, 95% CI: 1.27–4.84, p = 0.01), pneumothorax (AHR = 3.03, 95% confidence interval [CI]: 1.48–6.21, p = 0.003), vasoactive-inotropic score (VIS) at 24 h of age (AHR = 1.0026, 95% confidence interval [CI]: 1.0004–1.005, p = 0.026), and score for neonatal acute physiology II (SNAP-II) ≥ 43 (AHR = 4.03, 95% CI: 1.66–9.77, p = 0.005) were associated with an increased risk of mortality. The overall survival rate was 82.4%; it rose from 63.8% to 87.1% after inhaled nitric oxide (iNO) and extracorporeal membrane oxygenation (ECMO) were introduced (p < 0.001). The cumulative survival rates at the end of the 30 days were 62.1% (95% CI: 49.0–78.7) in the Pre-iNO era and 87.5% (95% CI: 82.7–92.6) in the Post-iNO/ECMO era, respectively (p < 0.001). Conclusions: GA less than 28 weeks, SGA, AKI, pneumothorax, high VIS and SNAP-II scores were associated with mortality in infants with PPHN. The improvement in the survival rate was related to the provision of advanced care, including iNO and ECMO therapy. Full article
(This article belongs to the Special Issue Clinical Diagnosis and Management of Neonatal Diseases)
►▼ Show Figures

Figure 1

13 pages, 236 KiB  
Article
Changes in the Incidence and Severity of NEC over the Last Decade: A Single-Center Study
by Noa Ofek Shlomai, Meshy Tayeb, Rawan Abu Omar and Smadar Eventov Friedman
J. Clin. Med. 2025, 14(10), 3551; https://doi.org/10.3390/jcm14103551 - 19 May 2025
Viewed by 658
Abstract
Background: Necrotizing enterocolitis is the leading gastrointestinal cause of morbidity and mortality in neonatal intensive care units. Despite advancements in neonatal care, the incidence of NEC remains unchanged. This study evaluated trends in NEC incidence and severity over the past decade and identified [...] Read more.
Background: Necrotizing enterocolitis is the leading gastrointestinal cause of morbidity and mortality in neonatal intensive care units. Despite advancements in neonatal care, the incidence of NEC remains unchanged. This study evaluated trends in NEC incidence and severity over the past decade and identified associated risk factors in our NICU population. Methods: This was a retrospective cohort study comparing the prevalence and severity of NEC among VLBW infants born before 32 weeks of gestation across the following two periods: 2012–2016 and 2017–2021. Clinical data were extracted from medical records, with NEC diagnosis and grading based on the modified Bell’s criteria. Results: A total of 299 infants were included. Those born in the later period were significantly more preterm and had lower birth weights. While the overall NEC incidence increased in the later cohort, the rate of surgical NEC was lower. Logistic regression identified hemodynamic instability requiring pressor support, late-onset sepsis, and earlier gestational age as significant risk factors for NEC. Conclusions: Although the incidence of NEC was higher in the later cohort, its severity was lower compared to the earlier cohort. These findings suggest that advancements in neonatal care and feeding protocols may contribute to improved outcomes. Early NEC stages may represent alternative intestinal or systemic conditions warranting further research for better diagnosis. Full article
(This article belongs to the Special Issue Clinical Diagnosis and Management of Neonatal Diseases)
14 pages, 922 KiB  
Article
Postural Analysis in Ventral and Dorsal Decubitus Babies Using Deep Learning Techniques: A Protocol Study
by Sara Velázquez-Iglesias, Vidal Moreno-Rodilla, Belén Curto-Diego, Fátima Pérez-Robledo, Rocío Llamas-Ramos, Jose Ignacio Calvo-Arenillas and Inés Llamas-Ramos
J. Clin. Med. 2025, 14(9), 3096; https://doi.org/10.3390/jcm14093096 - 30 Apr 2025
Viewed by 501
Abstract
Background: The analysis of posture in the early stages of motor development has always been a subject of research and study. With the evolution of new technologies, the need arises to implement evaluation tools that allow an objective and effective assessment of postural [...] Read more.
Background: The analysis of posture in the early stages of motor development has always been a subject of research and study. With the evolution of new technologies, the need arises to implement evaluation tools that allow an objective and effective assessment of postural control, which is intrinsically linked to motor development. Objectives: The objective was to analyze posture in babies from 0 to 6 months in ventral and dorsal decubitus using artificial intelligence to determine objective parameters of postural assessment. Methods: The study is an observational and cross-sectional study. The babies will be studied following a systematic kinesiological assessment, and the images of the babies will be taken, both in ventral and dorsal decubitus, on a glass platform, to analyze their posture by means of deep learning techniques. Results: Many authors have investigated posture in newborns. However, there is no method for assessing motor and postural development to determine the support area of typically developing babies. Artificial intelligence is postulated as an effective tool to objectively analyze the posture of babies and detect possible delays. Using deep learning techniques as a predictive tool, the support areas of each baby will be defined according to their age. Conclusions: Early detection of motor or postural developmental delays in babies to optimize effective treatment is of great importance. Artificial intelligence can help manage the complexity and growing volume of data in healthcare by knowing the correct postural control at each stage of a baby’s early months, while reducing the workload of healthcare professionals by facilitating decision-making. Full article
(This article belongs to the Special Issue Clinical Diagnosis and Management of Neonatal Diseases)
►▼ Show Figures

Figure 1

11 pages, 957 KiB  
Article
The Effect on Extubation of Early vs. Late Definitive Closure of the Patent Ductus Arteriosus in Premature Infants: A Target Trial Emulation Using Electronic Health Records
by Zhou Du, Craig R. Wheeler, Michael Farias, Diego Porras, Philip T. Levy and Arin L. Madenci
J. Clin. Med. 2025, 14(6), 2072; https://doi.org/10.3390/jcm14062072 - 18 Mar 2025
Viewed by 686
Abstract
Background/Objectives: Premature infants are often referred for the definitive procedural closure of the patent ductus arteriosus (PDA) with the failure of, or contraindication to, pharmacotherapy and the inability to wean respiratory support. However, once this need is identified, the importance of expedited [...] Read more.
Background/Objectives: Premature infants are often referred for the definitive procedural closure of the patent ductus arteriosus (PDA) with the failure of, or contraindication to, pharmacotherapy and the inability to wean respiratory support. However, once this need is identified, the importance of expedited closure is unclear. The objective of this study was to compare the effect of the timing of definitive closure (i.e., surgical ligation or device occlusion) on early respiratory outcomes in premature infants. Method: We first specify a hypothetical randomized trial (the “target trial”) that would estimate the effect on extubation of early (0–4 days from referral) vs. late (5–14 days from referral) definitive PDA closure. We then emulate this target trial using a single-institution registry of premature infants (born <30 weeks or with a birth weight < 1500 g) who underwent the definitive closure of PDA between January 2014 and October 2023. Results: We identify 131 eligible infants. At the end of the follow-up, 70 and 38 infants were adherent to early and late PDA closure strategies, respectively. The cumulative incidence of extubation in the early group was higher than that in the late group until day 40 (maximum risk difference: 22 percentage points at day 13; 95% CI: −11 to 56). Outcomes were similar at the end of the 45-day follow-up period (risk difference: −1 percentage point; 95% CI: −46 to 42). Conclusions: The need for mechanical ventilation was equivalent between early and late PDA closure strategies at the end of a 45-day follow-up period although infants in the early intervention group were extubated sooner. Full article
(This article belongs to the Special Issue Clinical Diagnosis and Management of Neonatal Diseases)
►▼ Show Figures

Figure 1

Review

Jump to: Research

17 pages, 296 KiB  
Review
Oxygen Saturation Targeting in the Neonatal Intensive Care Unit
by Faeq Almudares, Bheru Gandhi, Jonathan Davies, Xanthi Couroucli, Natalie Villafranco, Nidhy Paulose Varghese, Milenka Cuevas Guaman, Charleta Guillory and Binoy Shivanna
J. Clin. Med. 2025, 14(11), 3975; https://doi.org/10.3390/jcm14113975 - 4 Jun 2025
Viewed by 1212
Abstract
Oxygen (O2) is vital for cellular development, function, proliferation, and repair, underscoring its critical role in organogenesis. Both hypoxia (reduced tissue O2) and hyperoxia (excess tissue O2), when prolonged, can trigger inflammation and oxidative stress, contributing to [...] Read more.
Oxygen (O2) is vital for cellular development, function, proliferation, and repair, underscoring its critical role in organogenesis. Both hypoxia (reduced tissue O2) and hyperoxia (excess tissue O2), when prolonged, can trigger inflammation and oxidative stress, contributing to acute and long-term cardiopulmonary and neurodevelopmental morbidity. In sick neonates, immature defense mechanisms and coexisting morbidities demand nuanced and sometimes opposing strategies for O2 saturation targets and therapeutic titration. Most current neonatal O2 targeting guidelines are based on animal models or small clinical studies, resulting in recommendations with limited evidence. This narrative review aims to provide an updated overview of the physiological roles of O2 in development, its delivery and consumption, approaches to O2 saturation monitoring, and therapeutic targeting in neonates under both normal and pathological conditions. We also highlight key knowledge gaps and propose directions for future research on neonatal O2 saturation targeting. Full article
(This article belongs to the Special Issue Clinical Diagnosis and Management of Neonatal Diseases)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-6
Back to TopTop